About Nordvacc

koncern-header

 

Nordvacc Pharmaceuticals was founded in 1988 in Stockholm and has to date established local offices in Denmark, Finland, Latvia and Lithuania. To date we have developed and commercialized a number of conventional vaccines and sold more than 150 million doses of vaccine.

Background

Nordvacc Läkemedel AB Stockholm, Sweden has its origin in the 1980:s following an aquisition of the vaccine rights of the National Veterinary Institute in Uppsala, Sweden.

In 1991 Nordvacc established its first longlasting cooperation with the German vaccine company IDT, member of the Klocke Pharma Group, in Karlsruhe Germany. Since the start of the cooperation between the two Groups more than 125 million doses have been produced by IDT and sold by Nordvacc to 11 European countries.